ML372 blocks SMN ubiquitination and improves spinal muscular atrophy pathology in mice-Reference-Cited by-同舟云学术

ML372 blocks SMN ubiquitination and improves spinal muscular atrophy pathology in mice

Published:2016-11-17 Issue:19 Volume:1 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Abera Mahlet B.,Xiao Jingbo,Nofziger Jonathan,Titus Steve,Southall Noel,Zheng Wei,Moritz Kasey E.,Ferrer Marc,Cherry Jonathan J.,Androphy Elliot J.,Wang Amy,Xu Xin,Austin Christopher,Fischbeck Kenneth H.,Marugan Juan J.,Burnett Barrington G.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference48 articles.

1. Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of >72 400 specimens

2. Spinal Muscular Atrophy: Journeying From Bench to Bedside

3. Spinal muscular atrophy;D’Amico;Orphanet J Rare Dis,2011

4. Spinal muscular atrophy: Diagnosis and management in a new therapeutic era

5. Identification and characterization of a spinal muscular atrophy-determining gene

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of the orally bioavailable 4-phenylbutyrate-tethered trichostatin A analogue AR42 in models of spinal muscular atrophy;Scientific Reports;2023-06-26

2. SMN post-translational modifications in spinal muscular atrophy;Frontiers in Cellular Neuroscience;2023-02-17

3. A combinatorial approach increases SMN level in SMA model mice;Human Molecular Genetics;2022-04-14

4. Hyper-SUMOylation of SMN induced by SENP2 deficiency decreases its stability and leads to spinal muscular atrophy-like pathology;Journal of Molecular Medicine;2021-10-09

5. Spinal muscular atrophy: From approved therapies to future therapeutic targets for personalized medicine;Cell Reports Medicine;2021-07